09.10. – 11.10.2018
bioLIVE is a global exhibition and content platform that serves as a global hub for both upstream and downstream processing and manufacturing. It connects biotechs, big pharma and service providers including CDMOs and CROs from early stage development to commercial manufacturing and regulatory services. It also features biogeneric and bioinnovator audiences through to manufacturing and laboratory specialists.
bioLIVE runs in parallel to its enormous contract services (ICSE) and small molecule (CPHI Worldwide) exhibitions – both currently the world’s largest in their respective areas – creating natural synergies and establishing the first truly global hub covering the entire biopharma and pharma supply chain.
With the global biopharmaceuticals market estimated to growth of CAGR of 8.6% from 2017 to 2021, to reach an estimated value of US$ 291 billion by 2021 (source: Mordor Intelligence: Global Biopharmaceuticals Market growth, Trends & Forecasts (2017-2022), a number of top trends are emerging, pushing the need for improved productivity and efficiency.
IFEMA, Feria de Madrid